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The investigation of amino acids is of fundamental interest to
scientists from many diverse ﬁelds. This interest derives from
their role as the basic constituents of proteins in addition to
their ability to serve as building blocks for the production of
many classes of secondary metabolites.
a-Amino acids play an important role in different areas be-
cause of the wide spectrum of activity they have (enzymology,
medicine and pharmacology, industry, asymmetric synthesis,18 788 704.
yahoo.fr (E.H. Mabrouk).
y. Production and hosting by
Saud University.
lsevier. . .) (Beers et al., 1996; Mikolajczyk, 2005; Joly and Jacobsen,
2004; Leite et al., 2006; Moreira et al., 2007).
This has led to the development of numerous synthetic
methods for a variety of compounds (Haemers et al., 1989).
The recent literature is enriched with progressive ﬁndings
about the synthesis and pharmacological action of fused het-
erocycles. Heterocycles bearing a symmetrical triazole and fur-
an are reported to show a broad spectrum of pharmacological
properties such as anti-inﬂammatory, antiviral and antibacte-
rial activities (Boschelli et al., 1993; Unangst et al., 1992; Hung
and Chen, 2001; Srivastava et al., 1984; Saad, 1996; Hui et al.,
2002).
Because of their multiple functionalities, amino acids het-
erocyclics play a considerable role in the biologic processes
(Costantino et al., 2004; Jorgensen et al., 2007). So a large
number of between them isolated of plants have a very varied
biologic activity (Schenk and Werner, 1991).
Over the past decades, nitrogen-containing heterocyclic
molecules have been considered as the privileged synthetic
targets in the pharmaceutical and veterinary industries
(Katritzky et al., 1996; Undheim and Benneche, 1999; Joule
and Mills, 2000; Katritzky et al., 2003) because of their diverse
Table 1 Synthesis of new a-aminoesters and a,a-diaminoesters derivatives 2–4.
Product Nu-H m.p. (C) Reaction
time (h)
–
DCM
Et3N
DCM
Et3N
acetone
DIEPA
DCM
DIEPA
acetone
Yield (%) Yield (%) Yield (%) Yield (%) Yield (%)
2 3-Amino-1,2,4-triazole 214–216 48 Traces 19 33 42 77.5
3 2-Tetrahydrofuran-2-ylmethanamine 130–132 48 Traces 17.5 30.5 39 72
4 2-Methylquinolin-4-amine 158–160 72 Traces 14.5 25.5 32.5 60
DCM: dichloromethane, Et3N: triethylamine.
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anticancer, diuretic, anticonvulsant, anti-inﬂammatory and
anti-hypertensive activities (Chan et al., 1997; Gackenheimer
et al., 1996; Dempcy and Skibo, 1991).
The 1,2,4-triazole and its derivatives were reported to exhi-
bit various pharmacological activities, such as antimicrobial,
analgesic, anti-inﬂammatory, anticancer and antioxidant prop-
erties (Padmavathi et al., 2008; Amir et al., 2008; Sztanke
et al., 2008; Kus et al., 2008). Some of the present day drugs,
such as Ribavirin (antiviral agent), Rizatriptan (antimigraine
agent), Alprazolam (anxiolytic agent), Fluconazole and Itrac-
onazole (antifungal agents) are the best examples for potent
molecules possessing triazole nucleus.
Quinaldine derivatives are very important photographic
sensitizers; they are used as dyes (textile, printing inks, and
food), drugs, cosmetics and indicators (Finar, 1995; Sanyal
et al., 1979; Shashidhar, 1974).
For this reason, we considered it interesting to synthesize
new compounds containing [1,2,4]-triazole nucleus, 2-tetrahy-
drofuran-2-ylmethanamine and 2-methylquinolin-4-amine
fused with a amino acid, in order to study their biological
activities. The present study describes the synthesis and charac-
terization of novel a-aminoesters derivatives.
2. Results
We continued our investigations on the use of organic azides
(Boukallaba et al., 2006, 2007) in heterocyclic synthesis; we re-
ported in this paper another part of our investigations con-
cerning the preparation of new carboxylic a,a-diaminoesters
carrying a variety of heterocyclic in position a.
Our strategy is based on the nucleophilic substitution of
methyl a-azido glycinate N-benzoylated 1 with aminesC
O
NH CO2CH3
Base / Sol
NuH
Nu-H =
NH2
N
NH
N
NH
CH
O
N3
1
;
Scheme(Scheme 1). Azide derivative 1 was prepared using Steglich
method (Steglich and Kober, 1983) and Achamlale’s procedure
(Achamlale et al., 1997, 1999).
Methyl a-azido glycinate N-benzoylated 1 was obtained by
the reaction (Achamlale et al., 1997, 1999) of sodium azide
with the methyl a-bromo glycinate. The title compound is sta-
ble and can be stored for an unlimited time without any signs
of decomposition. The methyl a-bromo glycinate also can be
used and gives satisfactory results; the azide 1 is used especially
for its stability.
The reaction of different amines Nu on azide derivative 1
results in Compounds 2–4 carrying heterocyclic amines.
As a ﬁrst step and to optimize the different reaction condi-
tions (choice of base, solvent, . . .), we conducted several test
reactions. For all these tests, the reactions were followed by
TLC and 1H NMR. Yields are given as pure product after
column chromatography on silica gel.
After several attempts of reactions without base or in the
presence of bases such as triethylamine, reaction with diisopro-
pylethylamine (DIEPA) gave the best results. The reaction was
carried out in dry acetone at room temperature. Results are
summarized in Table 1.
The products 2–4 were obtained in 60–77.5% overall yield
from 1 and were analyzed by MS, 13C NMR and 1H NMR.
For the reaction of 3-amino-1,2,4-triazole with azide 1, our
estimate was to have two products with the predominance of
one over another, but the spectroscopic data obtained showed
the existence of only a single product: methyl 2-benzamido-2-
(3-amino-1,2,4-triazol-1-yl) acetate 2 (Scheme 2).
Comparing these results with the work done by our team
(Boukallaba et al., 2006, 2007): synthesis of new a-heterocyclic
a-aminophosphonates and synthesis of a-heterocyclic a-ami-
nophosphonates, Part II: morpholine, piperidine, pyrrolidine,C
O
NH CO2CH3
vent
2
2
NH2
N CH3
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2 - 4
;
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aniline derivatives, we see that we have obtained almost the
same results.
The methyl glycinate prepared may be protected by differ-
ent protecting groups: triﬂuoroacetic anhydride, trichloroeth-
oxycarbonyl chlorides, acetyl chloride and benzoyl chloride.
The protection reaction is carried out in dichloromethane in
the presence of triethylamine or pyridine. After column
chromatography on silica gel the aminoesters N-protected
are obtained in good yields.3. Conclusion
In conclusion, this method provides general and convenient ac-
cess to a wide range of a,a-diaminoesters and a-aminoesters
derivatives starting from the appropriate azide derivative 1.
The nucleophilic substitution of methyl a-azido glycinate
N-benzoylated 1 with different amines (3-amino-1,2,4-triazole,
2-tetrahydrofuran-2-ylmethan-amine and 2-methylquinolin-4-
amine) occurred under very mild conditions and led to the
desired products in good yields.4. Experimental
4.1. General
Melting points were determined with an electrothermal melting
point apparatus and are uncorrected. NMR spectra (1H, 13C)
were recorded on a Bruker AM 300 (operating at
300.13 MHz for 1H, at 75.47 MHz for 13C) spectrometer
(Centre Universitaire Re´gional d’Interface, Fe`s). NMR data
are listed in ppm and are reported relative to tetra-methylsilane
(1H, 13C); residual solvent peaks being used as an internal stan-
dard. All reactions were followed by TLC. TLC analyses were
carried out on 0.25 mm thick precoated silica gel plates (Merck
Fertigplatten Kieselgel 60F254) and spots were visualized
under UV light or by exposure to vaporized iodine. Mass
spectra were recorded on a PolarisQ Ion Trap GC/MSn MassSpectrometer (Centre Universitaire Re´gional d’Interface, Fe`s);
except for the product 3 which was identiﬁed by electrospray
on a micromass ESl Platform II (Universite´ Montpellier II,
France). Methyl a-azidoglycinate 1 was prepared using
Achamlale’s method (Achamlale et al., 1997, 1999).
4.2. Typical procedure for nucleophilic substitution
To a stirred solution of 2.86 mmoles of amines (nitrogen
compounds) and 3.12 mmoles of diisopropylethylamine in
10 ml of dry acetone, 2.6 mmoles of methyl a-azido glycinate
were added. The mixture was stirred at room temperature
and the reaction was followed by TLC (Kiesegel Merck
60F524). The solvent was evaporated under reduced pres-
sure. The residue was quenched with saturated aqueous solu-
tion of ammonium chloride (20 ml) and extracted with
dichloromethane (20 ml · 3). The organic phase was dried
in sodium sulfate (Na2SO4) and the solvent was removed un-
der reduced pressure. The product was puriﬁed wherever nec-
essary by column chromatography on silica gel using ether/
hexane as eluant to afford pure nucleophilic substitution
product.
4.3. Methyl 2-benzamido-2-(3-amino-1,2,4-triazol-1-yl) acetate
2: yield: 77.5%; mp
214–216 C (ether/hexane); Rf: 0.3 (ether) 1H NMR (CDCl3):
dppm: 3.9 (s, 3H, OCH3); 5.6 (br s, 2H, NH2); 6.45 (d, 1H,
J= 7.2 Hz, Ha); 7.47–8.05 (3 m, 7H, Ar + Htria-
zol + NHamid).
13C NMR (CDCl3): dppm: 54.04 (OCH3);
60.67 (–CH–); 106.42, 127.42, 128.92, 133.01, 149.92, 155.70,
(C6H5 aromatic carbons); 165.62, 168.16 (2CO). M.S-E.I: m/
z= 275.8 [M]; C12H13N5O3.
C NH CH C O CH3
O O
N
N
N
H2N4.4. Methyl 2-benzamido-2-[(tetrahydro-furan-2-
ylmethyl)amino]acetate 3: yield
72%; m.p.: 130–132 C (ether/hexane); Rf: 0.6 (ether); 1H
NMR (CDCl3): dppm: 1.2–1.75 (2 m, 5H, HT.H.F); 2.9 (m,
2H, NCH2); 3.75 (s, 3H, OCH3); 4.1–4.45 (2 m, 3H,
HT.H.F + NH); 5.6 (br s, 1H, Ha); 7.4–8.02 (3 m, 5H, Ar + N-
Hamid).
13C NMR (CDCl3): dppm: 4· (CH2) 24.13, 27.07,
50.25, 66.12; 54.49 (OCH3); 71.32 (–CH–); 77.23 (OCH);
128.34, 129.54, 131.33, 135.77 (C6H5 aromatic carbons);
169.07, 171.98 (2CO). MS (electrospray) m/z= 293.3
[M+1]; 292.3 [M]; C15H20N2O4.
96 E.H. Mabrouk et al.C NH CH C O CH3
O O
NH
O4.5. Methyl 2-benzamido-2-(2-methylquinolin-4-ylamino)
acetate 4
yield: 60%; m.p.: 158–160 C (ether/hexane); Rf: 0.6 (ether);
1H NMR (CDCl3 ): dppm: 3.57 (3H, s, CH3); 3.88 (s, 3H,
OCH3); 4.9 (br s, 1H, NH); 5.8 (d, 1H, J= 9.0 Hz, Ha); 6.2
(br s, 1H, Ar); 6.7–7.9 (3 m, 10H, Ar + NHamid).
13C NMR
(CDCl3 ): dppm: 24.13 (CH3); 53.08 (OCH3); 56.98 (–CH–);
78.69, 109.23, 116.34, 120, 125.33,127.25, 128.77,132.38, 133,
149.12, 149.23, 159.77, (C6H5 aromatic carbons); 168.58, 171
(2CO) M.S-E.I: m/z= 349.1 [M]; C20H19N3O3.
N
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